Life Science Deal Flow focuses upon the – at times – overlooked pre-commercial entity and works diligently to bring you the latest on early-stage therapeutic, diagnostic and device companies – the news breaking, the funds raised, the investors participating, the technologies pursued, the trials designed, the data yielded, the regulatory pathway pursued and the products and indications approved.
No comments:
Post a Comment